for Japanese
See more
See all
Interim Report for the 97th Business Period, Ended September 30, 2020 (PDF:5.8 MB)
Quarterly Financial Results for the 2nd Quarter, Ended September 30, 2020 (PDF:870 KB)
Quarterly Financial Summary for the 2nd Quarter, Ended September 30, 2020 (PDF:764 KB)
Kaneka announced Medium-Term Management Plan (FY2020-2022) (PDF:6.0 MB)
Financial Section 2020 (PDF:807 KB)
Quarterly Financial Results for the 1st Quarter, Ended June 30, 2020 (PDF:521 KB)
Quarterly Financial Summary for the 1st Quarter, Ended June 30, 2020 (PDF:821 KB)
Kaneka strengthens efforts to manufacture COVID-19 DNA vaccine candidate
Kaneka launching “Milk Tea for Bread™”
Kaneka launches a joint research group of biomedicine production technologies with University of Louvain (UCLouvain), Belgium.
Kaneka develops super heat-resistant polyimide film for 5G millimeter wave zones
Approval acquired to manufacture and sell Adsorption Type Blood Purification Device for the most severe form of arteriosclerosis obliterans
